Delivery Order SPE2DB20D1100-SPE2DB24FD7E2
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FU4L5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,859.91 firm fixed-price delivery order is for the supply of the medication Budesonide-Formoterol 80-4.5 10.2GM. The contract has an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF0D0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,661.14 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. This award is part of a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,789.30 firm fixed price delivery order is for the supply of budesonide-formoterol 160-4.5 10.2GM, a prescription medication. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen is the prime contractor and no set-aside designation is mentioned. This contract award appears to be part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,289.97 delivery order contract is for the delivery of budesonide-formoterol 160-4.5 10.2 gram medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 25, 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,515.72 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat asthma and chronic obstructive pulmonary disease. The contract has an ultimate completion date of September 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
This federal contract award, identified as SPE2DB20D2002|SPE2DB25FL01V, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,867.54, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of November 12,...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $2,921.57. The award is for the procurement of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,720.49 firm fixed-price delivery order (SPE2DB22D1103|SPE2DB25FTEE2) is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The $1,022.52 firm fixed-price contract has a completion date of March 17, 2022 and was awarded on March 16, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop Support Medical, valued at up...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,462.06, is for the delivery of budesonide-formoterol 80-4.5 10.2GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of October 18, 2023. The contract does not have a set-aside designation, indicating open competition....